Coya Therapeutics (COYA) Asset Utilization Ratio (2023 - 2026)

Coya Therapeutics (COYA) reported Asset Utilization Ratio of 0.15 for Q1 2026, up 72.71% on a YoY basis from 0.09 in Q1 2025, and down 20.63% sequentially from 0.19 in Q4 2025.

Coya Therapeutics (COYA) Asset Utilization Ratio (2023 - 2026) Analysis & Trends

Coya Therapeutics (COYA) has 4 years of Asset Utilization Ratio data on file, last reported at 0.15 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 72.71% year-over-year to 0.15; the trailing twelve-month figure through Mar 2026 stood at 0.15 (up 72.71% YoY), and the FY2025 full-year result was 0.17, up 102.97% from the prior year.
  • Asset Utilization Ratio eased to 0.15 in Q1 2026, from 0.19 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.25 in Q3 2024 to a low of 0.01 in Q2 2025.
  • A 4-year average of 0.15 and a median of 0.15 in 2024 frame the typical range for Asset Utilization Ratio.
  • Peak annual rise in Asset Utilization Ratio reached 117.86% in 2025, while the deepest fall reached 95.23% in 2025.
  • Tracing COYA's Asset Utilization Ratio over 4 years: stood at 0.23 in 2023, then tumbled by 60.61% to 0.09 in 2024, then surged by 117.86% to 0.19 in 2025, then decreased by 20.63% to 0.15 in 2026.
  • Business Quant data shows COYA's Asset Utilization Ratio at 0.15 in Q1 2026, 0.19 in Q4 2025, and 0.12 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 0.69
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 0.37
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Coya Therapeutics 97.14 Mn 46.42 Mn - 0.15

Historic Data

Download Data
DateValue
Mar 31, 2026 0.15
Dec 31, 2025 0.19
Sep 30, 2025 0.12
Jun 30, 2025 0.01
Mar 31, 2025 0.09
Dec 31, 2024 0.09
Sep 30, 2024 0.25
Jun 30, 2024 0.25
Mar 31, 2024 0.16
Dec 31, 2023 0.23